🔬 The BioAI Phase Shift - Matthew McPartlon & Neil Patil, Chai Discovery
This January, four big AI × Pharma tools deals were announced at the huge JPM Pharma conference that takes over San Francisco every year. OpenAI-backed Chai Discovery (now worth $4B) was somehow at the heart despite being all of 2 years old. The Scienc... Full show notes and links
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Latent Space: The AI Engineer Podcast
See all episodes →
64%🔬Scaling Past Informal AI - Carina Hong, Axiom Math
57%Why Agents Love Supabase
57%⚡ An Eval for AI Scientists That Knows the Answer Key - Ian Quigley, Leash Bio
Similar episodes from other shows
More like Latent Space: The AI Engineer Podcast →
Chai-2: The AI Model Accelerating Drug Discovery with Chai Discovery Co-Founders Jack Dent and Joshua Meier
The 5 Most Impactful AI Model Releases of 2025
EP 32: AI Discovers Drugs: The 2026 Clinical Trial Moment for AI in Biotech
a16z Podcast: Deep Learning for the Life Sciences
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.